Your browser is no longer supported. Please, upgrade your browser.
NUVA NuVasive, Inc. daily Stock Chart
NuVasive, Inc.
Index- P/E169.15 EPS (ttm)0.41 Insider Own0.10% Shs Outstand51.74M Perf Week-1.70%
Market Cap3.62B Forward P/E25.65 EPS next Y2.73 Insider Trans0.00% Shs Float51.03M Perf Month1.60%
Income22.40M PEG10.31 EPS next Q0.62 Inst Own- Short Float10.52% Perf Quarter23.55%
Sales1.06B P/S3.41 EPS this Y67.50% Inst Trans4.50% Short Ratio8.71 Perf Half Y36.25%
Book/sh15.21 P/B4.60 EPS next Y14.51% ROA2.50% Target Price61.80 Perf Year30.80%
Cash/sh1.35 P/C51.69 EPS next 5Y16.40% ROE5.40% 52W Range44.62 - 72.12 Perf YTD19.73%
Dividend- P/FCF23.18 EPS past 5Y74.50% ROI7.30% 52W High-2.90% Beta0.69
Dividend %- Quick Ratio1.50 Sales past 5Y10.70% Gross Margin72.50% 52W Low56.95% ATR1.73
Employees2400 Current Ratio2.80 Sales Q/Q8.60% Oper. Margin6.70% RSI (14)61.26 Volatility2.72% 2.27%
OptionableYes Debt/Eq0.81 EPS Q/Q6.40% Profit Margin4.00% Rel Volume0.85 Prev Close70.45
ShortableYes LT Debt/Eq0.76 EarningsJul 31 AMC Payout0.00% Avg Volume615.97K Price70.03
Recom2.50 SMA20-0.22% SMA509.79% SMA20026.42% Volume524,167 Change-0.60%
Aug-01-18Reiterated Needham Buy $69 → $67
Jun-27-18Downgrade BofA/Merrill Neutral → Underperform
Jun-21-18Downgrade JP Morgan Overweight → Neutral
Jun-01-18Initiated Cantor Fitzgerald Neutral
May-02-18Reiterated Needham Buy $70 → $69
Apr-04-18Initiated Goldman Neutral $47
Feb-27-18Reiterated Needham Buy $71 → $70
Feb-01-18Downgrade Leerink Partners Outperform → Mkt Perform
Jan-17-18Downgrade Wells Fargo Outperform → Market Perform
Jan-04-18Upgrade Needham Underperform → Buy $71
Nov-10-17Reiterated RBC Capital Mkts Outperform $75 → $70
Oct-25-17Reiterated Canaccord Genuity Buy $75 → $70
Sep-07-17Initiated BTIG Research Buy $82
Aug-28-17Downgrade Needham Hold → Underperform
Jul-28-17Downgrade Robert W. Baird Outperform → Neutral $79 → $72
Jun-06-17Reiterated RBC Capital Mkts Outperform $76 → $85
Nov-30-16Initiated Aegis Capital Buy $72
Jul-27-16Reiterated Barclays Overweight $63 → $71
Jul-13-16Upgrade JP Morgan Neutral → Overweight $55 → $74
May-27-16Upgrade Barclays Equal Weight → Overweight $58 → $63
Sep-11-18 08:30AM  NuVasive Clinical Services Leader Richard Vogel Co-Chairs And Lectures At American Society Of Neurophysiological Monitoring 2018 Fall Symposium PR Newswire
Sep-07-18 11:06AM  What You Must Know About NuVasive Incs (NASDAQ:NUVA) 5.4% ROE Simply Wall St.
Sep-06-18 04:05PM  NuVasive To Present At The Morgan Stanley 16th Annual Global Healthcare Conference PR Newswire
Sep-05-18 04:26PM  Why Stryker decided a small Leesburg firm was the best buy to bolster its spinal business American City Business Journals
08:30AM  NuVasive Grows Expandable Spinal Interbody Portfolio With Launch Of TLX® 20 Degree Implant PR Newswire
Sep-04-18 04:02PM  NuVasive To Feature Lateral Single-Position Surgery And Surgical Intelligence At SMISS Annual Forum PR Newswire
Aug-30-18 11:05AM  Why Is NuVasive (NUVA) Up 8.3% Since Last Earnings Report? Zacks
Aug-20-18 06:05PM  Edited Transcript of NUVA earnings conference call or presentation 31-Jul-18 8:30pm GMT Thomson Reuters StreetEvents
Aug-16-18 08:40AM  NuVasive Appoints Dale Wolf To Lead Ohio Manufacturing Facility PR Newswire
Aug-09-18 08:30AM  NuVasive and Siemens Healthineers partner to transform spine surgery PR Newswire
Aug-03-18 11:45AM  Why This Healthcare Innovator Sees a Brighter Future Motley Fool
Aug-01-18 04:35PM  Why NuVasive, Inc. Stock Jumped Today Motley Fool +11.58%
12:14PM  NuVasive (NUVA) Q2 Earnings Meet Estimates, EPS View Down Zacks
Jul-31-18 06:10PM  NuVasive (NUVA) Q2 Earnings Match Estimates Zacks
05:08PM  NuVasive: 2Q Earnings Snapshot Associated Press
04:05PM  NuVasive Announces Second Quarter 2018 Financial Results PR Newswire
02:30PM  NuVasive, Inc. to Host Earnings Call ACCESSWIRE
08:53AM  NuVasive (NUVA) in Focus: Stock Moves 6.02% Higher Zacks
08:20AM  Today's Research Reports on Trending Tickers: Tandem Diabetes Care and NuVasive ACCESSWIRE
Jul-30-18 08:33AM  Medical Product Stock Earnings on Jul 31: HOLX, NUVA, QSII Zacks +6.02%
Jul-27-18 08:30AM  NuVasive Unveils Spine's First Integrated Surgical Automation Platform PR Newswire
Jul-19-18 05:30AM  Nuvasive Launches MAGEC X For Early Onset Scoliosis Treatment PR Newswire
Jul-16-18 07:05AM  Free Pre-Market Technical Recap on Nevro and Three Additional Medical Equipment Stocks ACCESSWIRE
05:30AM  NuVasive Portfolio Introduces Low-Profile Modular Implants For Posterior Fixation PR Newswire
Jul-11-18 04:10PM  NuVasive Announces Conference Call And Webcast Of Second Quarter 2018 Results PR Newswire
Jul-10-18 05:30AM  NuVasive Unveils Newest Addition To Lateral Procedural Solutions At IMAST 2018 PR Newswire
Jul-09-18 05:30AM  Research Highlights The Importance Of Spinal Alignment In All, Not Just Deformity, Lumbar Fusions PR Newswire
Jul-02-18 08:00AM  Pomerantz LLP Announces Proposed Class Action Settlement on Behalf of Purchasers of Common Stock of NuVasive, Inc. -- NUVA GlobeNewswire
Jun-29-18 11:24AM  Polaris,, BlackRock, Intuitive Surgical, Medtronic and NuVasive as Zacks Bull and Bear of the Day Zacks
Jun-28-18 02:20PM  3 Stocks to Tap the Minimally-Invasive Surgery Market Boom InvestorPlace
09:33AM  3 Stocks to Tap the Minimally-Invasive Surgery Market Boom Zacks
Jun-21-18 10:47AM  A Look At The Fair Value Of NuVasive Inc (NASDAQ:NUVA) Simply Wall St.
Jun-20-18 08:30AM  First Porous PEEK Spinal Implant Clinical Study Validates NuVasive Advanced Materials Science Technology In Treating Degenerative Cervical Disc Disease PR Newswire
Jun-15-18 08:30AM  Recent Analysis Shows NuVasive, Ecolab, Roku, Northern Trust, Sea Limited, and Twenty-First Century Fox Market Influences Renewed Outlook, Key Drivers of Growth GlobeNewswire
Jun-12-18 08:30AM  NuVasive Launches AttraX Scaffold Biologic And Reports First Clinical Use PR Newswire
Jun-11-18 08:30AM  NuVasive Announces Key Finance Appointments PR Newswire
Jun-05-18 04:02PM  NuVasive To Present At The Goldman Sachs Annual Global Healthcare Conference PR Newswire
10:12AM  NuVasive's (NUVA) Global Prospects Solid, Competition Rife Zacks
May-31-18 11:30AM  Kuros Biosciences to Propose Appointment of New Board Members at AGM GlobeNewswire
09:11AM  Why is NuVasive (NUVA) Down 5.7% Since its Last Earnings Report? Zacks
07:20AM  Breakfast Technical Briefing on NovoCure and Three Other Additional Medical Equipment Stocks ACCESSWIRE
May-29-18 08:42AM  Arcturus Therapeutics Appoints Four New Directors and Reaches Settlement Agreement with Founder Joseph E. Payne GlobeNewswire
May-23-18 08:30AM  Nuvasive SpineTRACK Registry Reaches Significant Enrollment Milestone Of 10,000 Patients PR Newswire
May-22-18 08:30AM  NuVasive PRECICE STRYDE System Used In First Patient For Stature Lengthening By International Limb Lengthening Expert PR Newswire
May-16-18 04:02PM  Edited Transcript of NUVA earnings conference call or presentation 1-May-18 8:30pm GMT Thomson Reuters StreetEvents
04:02PM  NuVasive Sponsors SOLAS 2018, Hosts Workshop On Latest Lateral Innovations PR Newswire
May-09-18 04:02PM  NuVasive To Present At The Bank of America Merrill Lynch 2018 Healthcare Conference PR Newswire
May-08-18 04:02PM  NuVasive Unveils Newest Additions To Early Onset Scoliosis Portfolio At POSNA Annual Meeting PR Newswire
May-02-18 08:33AM  NuVasive (NUVA) Q1 Earnings Miss Estimates, Revenues In Line Zacks -9.39%
May-01-18 04:14PM  NuVasive: 1Q Earnings Snapshot Associated Press
04:02PM  NuVasive Announces First Quarter 2018 Financial Results PR Newswire
Apr-24-18 04:02PM  NuVasive Sponsors AANS 2018, Hosts Workshops And Presentations On Latest Innovations PR Newswire
Apr-19-18 07:30AM  New Research: Key Drivers of Growth for NuVasive, Apptio, Apollo Investment, Uranium Energy, AECOM, and US Foods Holding Factors of Influence, Major Initiatives and Sustained Production GlobeNewswire
Apr-10-18 04:02PM  NuVasive Announces Conference Call And Webcast Of First Quarter 2018 Results PR Newswire
Apr-05-18 04:02PM  NuVasive Sponsors ISASS 2018, Hosts Workshops And Presentations PR Newswire
Apr-02-18 04:02PM  NuVasive Portfolio Now Includes ALIF Retractor Platform For Lateral And Supine Approaches PR Newswire
Mar-29-18 04:02PM  Research Shows NuVasive Porous PEEK Structure Maintains High Porosity After Impaction PR Newswire
Mar-28-18 10:31AM  Why Is NuVasive (NUVA) Up 4.6% Since Its Last Earnings Report? Zacks
Mar-19-18 10:30AM  Orthopedic Device Market Gains Momentum: 3 Stocks in Focus Zacks
Mar-07-18 10:21AM  NuVasive Gains From International Business Amid Pricing Woes Zacks
Mar-05-18 04:02PM  NuVasive to Participate in Investor Events in March 2018 PR Newswire
Feb-28-18 07:52AM  Edited Transcript of NUVA earnings conference call or presentation 26-Feb-18 9:30pm GMT Thomson Reuters StreetEvents
Feb-27-18 10:05AM  NuVasive (NUVA) Meets Q4 Earnings Estimates, Issues '18 View Zacks
Feb-26-18 05:45PM  NuVasive Sees a Stronger 2018 Motley Fool
04:39PM  NuVasive meets 4Q profit forecasts Associated Press
04:02PM  NuVasive Reports Fourth Quarter and Full Year 2017 Financial Results PR Newswire
12:15PM  NuVasive, Inc. to Host Earnings Call ACCESSWIRE
07:33AM  Does NuVasive Incs (NASDAQ:NUVA) Recent Track Record Look Strong? Simply Wall St.
Feb-22-18 10:36AM  International Business Aids NuVasive, Pricing Woe Remains Zacks
Feb-21-18 11:25AM  NuVasive's SpineTRACK Registry Gains New CMS Designation Zacks
Feb-20-18 04:05PM  NuVasive SpineTRACK Registry Named Qualified Clinical Data Registry By Centers Of Medicare And Medicaid Services PR Newswire
Feb-09-18 07:35AM  Research Report Identifies Ichor, TASER International, Premier, NuVasive, Verastem, and BLACKLINE INC with Renewed Outlook Fundamental Analysis, Calculating Forward Movement GlobeNewswire
Feb-08-18 04:05PM  John DeFord To Join NuVasive Board Of Directors PR Newswire
Feb-07-18 04:02PM  Nuvasive Announces Conference Call And Webcast Of Fourth Quarter And Full Year 2017 Results PR Newswire
Jan-12-18 09:45AM  Why Mizuho Securities Upgraded Teva Pharmaceutical to a Buy Market Realist
Jan-10-18 09:22AM  NuVasive Q4 Preliminary Results Fail to Cheer Investors Zacks
Jan-08-18 02:26PM  Here's What Pressured NuVasive, Inc. Stock Today Motley Fool -8.93%
08:30AM  NuVasive Announces Preliminary Unaudited Full Year 2017 Revenue Results And Preliminary 2018 Outlook PR Newswire
Jan-04-18 04:31PM  Medtech Player Bounds On Upgrade Amid Tax Reform, Acquisitions Investor's Business Daily
08:30AM  NuVasive Extends First-Of-Its-Kind Porous PEEK Interbody To TLIF And PLIF Procedures PR Newswire
Jan-03-18 04:02PM  NuVasive To Present At The 36th Annual J.P. Morgan Healthcare Conference PR Newswire
Jan-01-18 08:06AM  See what the IHS Markit Score report has to say about NuVasive Inc. Markit
Dec-28-17 12:31PM  ETFs with exposure to NuVasive, Inc. : December 28, 2017 Capital Cube
Dec-21-17 01:46PM  Medical device maker says savings from new tax law to fuel innovation and growth American City Business Journals
08:30AM  NuVasive Comments On Expected Impact Of U.S. Tax Reform PR Newswire
08:07AM  See what the IHS Markit Score report has to say about NuVasive Inc. Markit
Dec-20-17 08:46AM  NuVasive (NUVA) Global Prospects Solid, Pricing Woes Remain Zacks
Dec-14-17 04:02PM  NuVasive Appoints Experienced Spine Executive Michael Piccirillo To Lead New Global Surgeon Education Platform PR Newswire
07:50AM  NuVasive (NUVA) to Acquire SafePassage, Strengthens IONM Zacks
Dec-12-17 04:02PM  NuVasive To Acquire SafePassage PR Newswire
Dec-08-17 08:07AM  See what the IHS Markit Score report has to say about NuVasive Inc. Markit
Nov-30-17 08:06AM  See what the IHS Markit Score report has to say about NuVasive Inc. Markit
Nov-29-17 08:07AM  See what the IHS Markit Score report has to say about NuVasive Inc. Markit
Nov-27-17 08:06AM  See what the IHS Markit Score report has to say about NuVasive Inc. Markit
Nov-22-17 08:06AM  See what the IHS Markit Score report has to say about NuVasive Inc. Markit
Nov-20-17 12:54PM  5 Lesser-Known Rule Breakers: Where We Stand at the 2-Year Mark Motley Fool
08:06AM  See what the IHS Markit Score report has to say about NuVasive Inc. Markit
07:55AM  Research Report Identifies Hill-Rom, TASER International, Synchronoss Technologies, NuVasive, Verastem, and Roku with Renewed Outlook Fundamental Analysis, Calculating Forward Movement GlobeNewswire
Nov-17-17 08:08AM  See what the IHS Markit Score report has to say about NuVasive Inc. Markit
Nov-16-17 08:30AM  NuVasive To Participate In The 29th Annual Piper Jaffray Healthcare Conference PR Newswire
NuVasive, Inc., a medical device company, develops and markets minimally-disruptive surgical products and procedurally-integrated solutions for spine surgery. Its products focus on applications for spine fusion surgery, including ancillary products and services used to aid in the surgical procedure. The company's principal product is Maximum Access Surgery, a minimally-disruptive surgical platform, which includes its software-driven nerve detection and avoidance systems, and intraoperative monitoring (IOM) services and support; MaXcess, an integrated split-blade retractor system; and various specialized implants and biologics. Its spine surgery product line offerings comprise products for the thoracolumbar and the cervical spine, which are primarily used to enable surgeons to access the spine and to perform restorative and fusion procedures in a minimally-disruptive fashion. Its biologics products include Osteocel Plus and Pro, a cellular bone matrix; Formagraft, a collagen-based synthetic bone substitute; AttraX, a synthetic bone graft material; and Propel DBM, a moldable demineralized bone matrix putty, which are used for spinal fusion or bone healing process. The company's IOM services are used for onsite and remote monitoring of the neurological systems of patients undergoing spinal and brain-related surgeries. It also provides implants used for interbody disc height restoration; and fixation products, including pedicle screws, rods, and plates. In addition, the company offers Integrated Global Alignment platform for assessing, preserving, and restoring spinal alignment; MAGEC-early onset scoliosis, a spinal bracing and distraction system; and PRECICE, a limb lengthening system. NuVasive, Inc. sells its products to patients, surgeons, hospitals, and insurers through independent sales agents, directly-employed sales personnel, and distributors in the United States and internationally. The company was founded in 1997 and is headquartered in San Diego, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Leddy Peter MichaelEVP, People and CultureAug 01Option Exercise0.002,265016,801Aug 03 06:01 PM
OHALLERAN MICHAEL DDirectorAug 01Option Exercise0.003,161015,586Aug 03 05:58 PM
SISITSKY NATHANIELSVP & General CounselJul 01Option Exercise0.001,71005,218Jul 03 05:58 PM
OHALLERAN MICHAEL DDirectorMay 18Option Exercise0.002,130012,425May 22 05:57 PM
FARRELL PETER CDirectorMay 03Option Exercise10.3622,844236,70041,490May 07 05:59 PM
HOWE LESLEY HDirectorMay 03Option Exercise0.0015,247026,244May 07 05:57 PM
Rozow StephenEVP, Global ProcessMay 01Option Exercise0.001,68004,655May 03 05:42 PM
LUCIER GREGORY TChairman & CEOMar 06Buy50.306,000301,800141,516Mar 08 05:58 PM
LUCIER GREGORY TChairman & CEOMar 01Buy48.576,000291,420135,516Mar 05 05:55 PM
Rosenberg Donald JDirectorFeb 12Option Exercise0.005,96305,963Feb 14 05:57 PM
Sylvain Jereme MChief Accounting OfficerFeb 01Option Exercise0.0093108,323Feb 05 05:59 PM
Carol CoxEVP External AffairsFeb 01Option Exercise0.001,929014,829Feb 05 05:58 PM
Link MatthewEVP, Strategy, Tech & Corp DevFeb 01Option Exercise0.002,660087,170Feb 05 05:55 PM
LUCIER GREGORY TChairman & CEOFeb 01Option Exercise0.0013,9980134,423Feb 05 05:54 PM
Link MatthewEVP, Strategy, Tech & Corp DevDec 27Option Exercise38.787,500290,85089,835Dec 29 05:57 PM